Palpitation primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary Tags: mobile edit mobile web edit |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of palpitations. | There are no established measures for the [[primary prevention]] of [[palpitations]]. | ||
==Primary Prevention== | ==Primary Prevention== | ||
*There are no established measures for the primary prevention of palpitations. | *There are no established measures for the [[primary prevention]] of [[palpitations]]. | ||
*Effective measures for the primary prevention of palpitations include: <ref name="pmid21697315">{{cite journal| author=Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L | display-authors=etal| title=Management of patients with palpitations: a position paper from the European Heart Rhythm Association. | journal=Europace | year= 2011 | volume= 13 | issue= 7 | pages= 920-34 | pmid=21697315 | doi=10.1093/europace/eur130 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21697315 }} </ref> | *Effective measures for the [[primary prevention]] of [[palpitations]] include: <ref name="pmid21697315">{{cite journal| author=Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L | display-authors=etal| title=Management of patients with palpitations: a position paper from the European Heart Rhythm Association. | journal=Europace | year= 2011 | volume= 13 | issue= 7 | pages= 920-34 | pmid=21697315 | doi=10.1093/europace/eur130 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21697315 }} </ref> | ||
**Medication compliance | **[[Medication compliance]] | ||
**Avoidance of triggers such as caffeine intake, alcohol abuse. | **Avoidance of [[triggers]] such as [[caffeine]] intake, [[alcohol abuse]]. | ||
**Cessation of substance abuse (cocaine, amphetamines, alcohol, MDMA) | **Cessation of [[substance abuse]] ([[cocaine]], [[amphetamines]], [[alcohol]], [[MDMA]]) | ||
==References== | ==References== |
Latest revision as of 14:20, 16 August 2020
Palpitation Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Palpitation primary prevention On the Web |
American Roentgen Ray Society Images of Palpitation primary prevention |
Risk calculators and risk factors for Palpitation primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
Overview
There are no established measures for the primary prevention of palpitations.
Primary Prevention
- There are no established measures for the primary prevention of palpitations.
- Effective measures for the primary prevention of palpitations include: [1]
- Medication compliance
- Avoidance of triggers such as caffeine intake, alcohol abuse.
- Cessation of substance abuse (cocaine, amphetamines, alcohol, MDMA)
References
- ↑ Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L; et al. (2011). "Management of patients with palpitations: a position paper from the European Heart Rhythm Association". Europace. 13 (7): 920–34. doi:10.1093/europace/eur130. PMID 21697315.